Queen Mary University of London Spinouts vs Upstream Bio
Queen Mary University of London Spinouts vs Upstream Bio, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Queen Mary University of London Spinouts is on 7/100 and Upstream Bio on 61/100.
Where each one leads
Queen Mary University of London Spinouts
- domain rating: 84/100 against 32/100
Upstream Bio
- our overall score: 61/100 against 7/100
- agent readiness: 39/100 against 25/100
At a glance
| Measure | Queen Mary University of London Spinouts | Upstream Bio |
|---|---|---|
| What it is | A collective of grant-stage to Series A companies spun out from Queen Mary University of London, actively seeking investment in sectors like life sciences, AI, and sustainability. | Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases. |
| Category | Life Sciences, Sustainability, University Spinout, Technology Transfer | Life Sciences, Therapeutics, Biotech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | Not published | 2021 |
| Headquarters | London, United Kingdom | Waltham, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Queen Mary University of London Spinouts | Upstream Bio |
|---|---|---|
| Employees | Not published | 75 |
| Headcount growthLast 12 months | Not published | +43.4% |
| Total funding | Not published | $400M |
| Latest round | Funding Round | Series B |
| Valuation | $1.1B | Not published |
| LinkedIn followers | Not published | 11,799 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Queen Mary University of London Spinouts | Upstream Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 7/100 | 61/100 |
| Traction | Not published | 59/100 |
| Team | Not published | 70/100 |
| Search visibility | Not published | 37/100 |
| Quality | Not published | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (25/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 84/100 | 32/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Queen Mary University of London Spinouts | Upstream Bio |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | CloudFront | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Jquery, Tailwind CSS | Jquery, Bootstrap |
| Analytics | Google Tag Manager, Linkedin Insight | Google Tag Manager |
Queen Mary University of London Spinouts vs Upstream Bio: common questions
Which is better, Queen Mary University of London Spinouts or Upstream Bio?
On our 0-100 score Upstream Bio rates higher (61/100 against 7/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Queen Mary University of London Spinouts and Upstream Bio compare on the numbers?
Queen Mary University of London Spinouts leads on domain rating (84/100 against 32/100). Upstream Bio leads on our overall score (61/100 against 7/100), agent readiness (39/100 against 25/100).
Read the full Queen Mary University of London Spinouts review and pricing or the Upstream Bio review and pricing. You can also browse other Queen Mary University of London Spinouts alternatives we track.